The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Previous

Nutrition’s Role in Rebuilding Liver Cells After Beating Hepatitis C

Back to News Homepage

Next

New Virus Discovered: Human Hepegivirus-1 (HHpgV-1)

New Drug Combo Successful at Clearing All Hep C Genotypes

September 23, 2015

Print this page

Learn more about Gilead’s drug combination of velpatasvir and sofosbuvir, which is proving to be extremely effective in recent trials of clearing all strains of Hepatitis C.

Gilead’s hepatitis C drug works against all strains in trial

By Doni Bloomfield

Tuesday, September 22, 2015

An experimental hepatitis C drug combination from Gilead Sciences Inc. wiped out all strains of the virus in a large clinical trial, giving the company an advantage against AbbVie Inc. in the race to treat as many patients as possible.

In a trial of 624 patients with any of six strains, or genotypes, of hepatitis C, Gilead’s experimental combination of velpatasvir and sofosbuvir was effective at clearing the virus 99 percent of the time after 12 weeks of therapy. Three related trials also showed the drug was successful in treating multiple strains, the Foster City biotech company said this week.

Continue reading this entire article:
http://www.sfgate.com/business/article/Gilead-s-hepatitis-C-drug-works-against-all-6522464.php

10 Comments
Share
Share

Previous

Nutrition’s Role in Rebuilding Liver Cells After Beating Hepatitis C

Back to News Homepage

Next

New Virus Discovered: Human Hepegivirus-1 (HHpgV-1)

Requirements for using and reposting articles

Comments

HepatitisCentral.com provides information regarding hepatitis and liver disease. Comments are available to the community in order to discuss these topics and obtain answers to questions through community members. The Editors at HepatitisCentral.com will not be responding to questions or comments posed in article comments.

  • Mark Boyle

    Congrats Gilead, hopefully in all your research you can find a conscience to sell it at a affordable price. People are dying to see what you will do.

    • M Banks

      Amen to that.Shame on Gilead for not offering this drug at a price that the people who need it can live a Hep C free body.

    • David Gebhardt

      I disagree. Gilead invested 11 billion dollars on the company that they anticipated would come up with this drug, add to that the marketing and research cost. We need to understand that this IS a capitalistic society.

      • Beverly Bonasto

        I understand Gilead has agreed to sell Solvidad to India for $10 per pill to prevent them from developing their own treatment.

      • panthervic

        If Gilead has 20 billion invested they only have to sell 1.7 million pills to recoup that at the current price of $1200 per pill in the US. Bet they’ve already recouped their investment and are making a TON on all of us Americans. I guess that’s the way it’ll always work. We pay so the rest of the world gets it basically for free.

        • B. Hoyt

          Gilead got most of their development costs from the Nat. Health Inst.
          They have already recovered all of their out of pocket expenses and more. They are just another “greedy” pharmaceutical company. Also, Viekira made by Abbyvie costs “half” what Harvoni cost that is made by Gilead. The success rates are the same too.

      • B. Hoyt

        Most people do not know that Gilead got most of their development costs from the Nat. Health Inst.
        They have already recovered all of their out of pocket expenses and more. They are just another “greedy” pharmaceutical company. Also, Viekira made by Abbyvie costs “half” what Harvoni cost that is made by Gilead. The success rates are the same too.

  • Dodger

    Gilead’s existing hepatitis C drugs brought in $12.4 billion last year, even as the company faced criticism over list prices for the medicine that exceed $1,000 a day – I think they are getting some profit now.

  • Peggy Sucher

    Read up on Dr. Sofia, the man who discovered sofosbuvir (Sovaldi) He is a HERO….sold his patent for $11B then reinvested in another small lab to work on a vac for HCV and a CURE for HBV. turned down a job with Gilead as he prefers the small, sharing laboratory work rather than the giant corp pharma. with $11B I’d be buying Tahiti or something, but not him!

  • sue g

    I am on my second month of Sovaldi and Daklinza. One is from Gilead, the other is Bristol-Myers ,which kind of shocked me. I have had HepC for 35 years. Luckily years ago, my ex called and told me to get checked . I have Genotype 3, which is pretty much on the verge of cirrhosis. I was shocked I didn’t have it already, because I drank heavily after I found out for years. No more. I have Medicaid, and they turned me down. I was like, well, whatever. Then I filed an appeal and gee, suddenly they said ok. It is virtually at least a $180,000 treatment, which is outrageous. People (still) don’t realize you can get this through snorting cocaine or whatever thru straws and $100 bills. The virus stays alive for quite a while, and everyone is passing it around. In one second, you have it. This is what needs to be advertised besides using needles. I am waiting for my results from my last blood test. Then one month to go.. Maybe. Maybe its gone, maybe it won’t work. But thank goodness it is there. It was quite psychological for me for awhile, and then I forgot about, because there are no symptoms usually. And then I remembered it and BAM , there went my day. I don’t know a lot about these pharms, but I do know the amount is just ridiculous. Nothing costs that much to make . Now I see a Hepatitis E over on the side. What now? Good luck to everyone and blessed be.